FeesSafety
Pluang+

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Company Fundamentals
16 Nov 2026, 13:30 WIB
Na
View Source
Bullish
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhance shareholder value while allowing continued investment in its drug pipeline. The buybacks will be conducted on the open market by Morgan Stanley under a discretionary mandate. Shares repurchased will be held as treasury stock and may be used for employee incentive programs.

Lakefront Biotherapeutics' new €50 million share buyback program provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 16, 2026 14:02 WIB: out of 150 priced US health-sector stocks, 54 rose and 93 fell. Notable movers include NUWE at USD 5.02 with a -9.22% change, RLAY at USD 18.09 down -8.27%, and BNGO at USD 1.01 down -8.18%, with typical hold times ranging from 33 to 52 days on Pluang.

More News

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.

Exosens secured a firm order to supply 25,000 high-performance 4G+ image intensifier tubes to Theon Sensors for integration into night vision devices, with deliveries starting late 2026. This order is part of a long-term agreement through 2030 and in...

Market News
Bullish
57 minutes ago
Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.

Exosens has received a firm order for 25,000 high-performance 4G+ light intensifier tubes to equip night vision products for Theon, under a long-term supply agreement extended through 2030. The order includes options for an additional 35,000 tubes, p...

Market News
Bullish
57 minutes ago
Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank buys back 2.45M shares worth DKK 2.39B, owning 4.22% of its stock by Nov 2026.

Jyske Bank is conducting a share buyback program running from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-November 2026, the bank has repurchased 2,453,745 shares at an average price of DKK 974.50 per share...

Company Fundamentals
Bullish
1 hour ago
Jyske Bank buys back shares worth DKK 2.39 billion, holding 4.22% treasury shares as of November 2026

Jyske Bank buys back shares worth DKK 2.39 billion, holding 4.22% treasury shares as of November 2026

Jyske Bank has been actively repurchasing its shares under a program running from February 2026 to January 2027, acquiring shares worth up to DKK 3 billion. As of mid-November 2026, the bank has bought back shares valued at approximately DKK 2.39 bil...

Company Fundamentals
Neutral
1 hour ago
Chinese beauty innovation shines at 2026 INPD in Paris with OSM winning top RMB 1M award

Chinese beauty innovation shines at 2026 INPD in Paris with OSM winning top RMB 1M award

The 2026 International Cosmetics Innovation Summit and Awards (INPD) was held in Paris, showcasing Chinese beauty companies' innovations under the theme "REGENERATIONS." Sixteen Chinese brands received awards for breakthroughs in ingredients, formula...

Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App